Salomon & Ludwin’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.2K Sell
189
-7
-4% -$3.52K 0.01% 278
2025
Q4
$93.7K Hold
196
0.01% 251
2025
Q3
$84.2K Buy
196
+98
+100% +$38K 0.01% 262
2025
Q2
$37K Hold
98
﹤0.01% 298
2025
Q1
$33.9K Sell
98
-6
-6% -$1.93K ﹤0.01% 292
2024
Q4
$31.2K Sell
104
-3
-3% -$1.05K ﹤0.01% 295
2024
Q3
$43.5K Buy
107
+11
+11% +$4.03K ﹤0.01% 270
2024
Q2
$30.8K Sell
96
-310
-76% -$101K ﹤0.01% 314
2024
Q1
$135K Sell
406
-41
-9% -$12.5K 0.01% 219
2023
Q4
$110K Hold
447
0.01% 214
2023
Q3
$110K Buy
+447
New +$122K 0.01% 214

Other funds holding HCA

Salomon & Ludwin's HCA Position: Q1 2026 in Review

Salomon & Ludwin reduced its HCA Healthcare (HCA) stake by 3.6% in Q1 2026, selling an estimated $3.52K and leaving 189 shares worth $89.2K. The position accounts for 0.01% of the portfolio, ranked #278.

Salomon & Ludwin first reported a position in HCA in Q3 2023 and has held it in 11 quarters since. The position peaked at $135K in Q1 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Salomon & Ludwin held 189 shares of HCA Healthcare worth $89.2K as of Q1 2026.
  • Salomon & Ludwin sold 7 HCA Healthcare shares in Q1 2026, an estimated $3.52K.
  • HCA Healthcare made up 0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #278 holding.
  • Salomon & Ludwin first reported a position in HCA Healthcare in Q3 2023 and has held it in 11 quarters since.
  • Salomon & Ludwin's HCA Healthcare position peaked at $135K in Q1 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.